VPRIV

Indicated For

Type 1 Gaucher disease

About This Medication

# Takeda Patient Support Guide: Getting VPRIV at Low Cost ## About This Program Takeda Patient Support is a prescription assistance program designed to help patients with Type 1 Gaucher disease access VPRIV (velaglucerase alfa) affordably. Whether you're uninsured or have commercial insurance, this program may reduce or eliminate your out-of-pocket costs. ## Who Can Apply? You may qualify for Takeda Patient Support if you: - Have Type 1 Gaucher disease and a prescription for VPRIV - Are a U.S. resident - Meet household income requirements (limits vary by family size) - Are uninsured OR have commercial insurance **Note:** Income limits vary annually. Contact Takeda directly at (866) 888-0660 to confirm current thresholds for your household size. ## Insurance Requirements **If you have commercial insurance:** You must be enrolled in Takeda Patient Support to receive assistance. The program works alongside your existing coverage to help with copays, coinsurance, and deductibles. **If you're uninsured:** You qualify for direct assistance through the program based on income eligibility. **Medicare patients:** Takeda Patient Support does not cover Medicare beneficiaries. Explore other resources such as manufacturer coupons, state pharmaceutical assistance programs, or speak with your healthcare provider about alternatives. ## How to Apply: 4-Step Process **Step 1: Gather Required Documents** - OnePath Start Form (completed jointly with your doctor) - Patient Authorization form - Proof of insurance status (insurance card, denial letter, or uninsured documentation) **Step 2: Work with Your Doctor** Your healthcare provider must complete and sign the OnePath Start Form, which verifies your diagnosis, treatment plan, and medical necessity for VPRIV. **Step 3: Submit Your Application** You can apply through multiple channels: - Phone: Call (866) 888-0660 - Online: Visit https://www.vpriv.com/support-programs - Mail or fax options available through the program website **Step 4: Wait for Approval** Once submitted, Takeda reviews your application. Most decisions are made within 5-7 business days. You'll receive notification by phone or mail with next steps. ## What Happens After Approval Once approved, you'll receive: - Information about your benefit level - Instructions on how to access your medication - Details about copay savings (if applicable) - A patient resource kit with support information **Refills:** Your approval is valid for one year. You'll need to reauthorize annually to continue receiving assistance. **Savings Card Option:** The program offers a savings card that can reduce your copay at participating pharmacies, in addition to direct assistance. ## Income Guidelines Income limits vary based on household size and are adjusted annually. Examples of typical ranges include: - Single individual: varies by year (contact program for current amount) - Family of 4: varies by year (contact program for current amount) **These are approximate figures.** Call (866) 888-0660 for exact 2024 income limits matching your family size. ## Timeline Expectations - **Application submission:** Same day (phone) or 2-3 business days (mail/online) - **Processing:** 5-7 business days - **Approval notification:** Phone call or mailed letter - **Medication access:** Usually within 1-2 weeks of approval ## After Your Application Is Approved **Annual reauthorization:** Your assistance renews yearly. Takeda will contact you before your authorization expires to complete the reauthorization process. **If circumstances change:** Contact Takeda immediately if your insurance, income, or household situation changes significantly. This may affect your eligibility. ## Frequently Asked Questions For additional questions, visit https://www.vpriv.com/support-programs or call Takeda Patient Support at (866) 888-0660. Representatives are available to discuss eligibility, answer questions about the application process, and help troubleshoot any issues. ## Important Notes - This program is for VPRIV only. Other Gaucher disease treatments have separate assistance programs. - There are no biosimilar alternatives to VPRIV currently available. - Program details and income limits may change annually; verify current information before applying. - Your doctor's cooperation is essential—the OnePath Start Form requires their signature and medical information.

Program information last verified: March 25, 2026